Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JENNIFER D HOLMAN

Allopathic & Osteopathic Physicians Dermatology

NPI
1447354626
CMS profile
201421
Location
TYLER, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$54,747.58

125 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JENNIFER D HOLMAN

NPI 1447354626 · CMS profile ID 201421

Allopathic & Osteopathic Physicians / Dermatology

TYLER, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1447354626?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JENNIFER D HOLMAN, NPI 1447354626, CMS profile ID 201421. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1447354626?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). JENNIFER D HOLMAN, NPI 1447354626, CMS profile ID 201421. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1447354626?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
JENNIFER D HOLMAN, NPI 1447354626, CMS profile ID 201421, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 125 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1447354626?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

125 matching records · $54,747.58 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 125 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 125.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
E.R. Squibb & Sons, L.L.C. $18.2105/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015920795 CMS
ABBVIE INC. $15.0105/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494169 CMS
GENZYME CORPORATION $26.8605/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050078707 CMS
ABBVIE INC. $21.8005/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494167 CMS
Janssen Biotech, Inc. $8.0604/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988498861 CMS
ABBVIE INC. $4,550.0004/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494163 CMS
ABBVIE INC. $4,550.0004/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494165 CMS
ABBVIE INC. $19.4404/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494161 CMS
ABBVIE INC. $27.2004/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494149 CMS
ABBVIE INC. $1,732.5604/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494151 CMS
ABBVIE INC. $1,541.0604/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494153 CMS
ABBVIE INC. $143.4004/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494155 CMS
ABBVIE INC. $113.2904/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494157 CMS
ABBVIE INC. $650.0004/20/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494159 CMS
Sun Pharmaceutical Industries Inc. $24.0204/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053869759 CMS
Janssen Biotech, Inc. $19.0004/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988498877 CMS
ABBVIE INC. $50.0904/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494147 CMS
ABBVIE INC. $19.5304/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494145 CMS
GENZYME CORPORATION $26.8604/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050078703 CMS
ABBVIE INC. $15.7204/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494143 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.2304/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996802993 CMS
E.R. Squibb & Sons, L.L.C. $14.8504/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015920781 CMS
ABBVIE INC. $419.9803/30/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494139 CMS
ABBVIE INC. $7.7503/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494141 CMS
Lilly USA, LLC $16.6303/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031497745 CMS
LEO Pharma Inc. $26.4603/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053483459 CMS
Janssen Biotech, Inc. $9.4803/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988498847 CMS
UCB, Inc. $30.4703/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021661225 CMS
ABBVIE INC. $12.4403/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494137 CMS
Galderma Laboratories, L.P. $85.9303/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059703079 CMS
Janssen Biotech, Inc. $15.1103/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988498855 CMS
ABBVIE INC. $975.0003/21/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494135 CMS
Galderma Laboratories, L.P. $4,500.0003/21/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059703075 CMS
ABBVIE INC. $4.5303/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494131 CMS
ABBVIE INC. $3,250.0003/20/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494133 CMS
ABBVIE INC. $28.8003/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494129 CMS
ABBVIE INC. $4,550.0003/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494127 CMS
ABBVIE INC. $4,550.0003/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494123 CMS
ABBVIE INC. $4,550.0003/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494125 CMS
ABBVIE INC. $23.1003/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494119 CMS
ABBVIE INC. $178.9003/10/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494121 CMS
ABBVIE INC. $228.7303/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494109 CMS
ABBVIE INC. $80.6203/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494111 CMS
ABBVIE INC. $10.4803/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494113 CMS
ABBVIE INC. $28.1803/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494115 CMS
ABBVIE INC. $19.4303/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494117 CMS
ABBVIE INC. $243.7103/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494107 CMS
ABBVIE INC. $5.8403/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 997494105 CMS
E.R. Squibb & Sons, L.L.C. $20.2903/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015920717 CMS
Novartis Pharmaceuticals Corporation $19.4903/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992292617 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $156,751.49 300
PY2020 $102,708.03 147
PY2021 $65,232.97 142
PY2022 $85,543.88 160
PY2023 $54,747.58 125
PY2024 $83,448.26 166
PY2025 $73,946.88 143

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $234,730.64 20
PY2024 Principal investigator $47,919.86 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

20 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $16,187.20 12/04/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202527556
Principal investigator 1 ABBVIE INC. $865.39 12/04/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202527774
Principal investigator 1 ABBVIE INC. $1,540.00 12/03/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202526390
Principal investigator 1 ABBVIE INC. $13,346.60 11/05/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202522151
Principal investigator 1 ABBVIE INC. $760.00 10/09/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202515007
Principal investigator 1 ABBVIE INC. $21,259.05 10/09/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202515183
Principal investigator 1 ABBVIE INC. $30,374.55 09/04/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202509268
Principal investigator 1 ABBVIE INC. $20,627.30 08/06/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202502502
Principal investigator 1 ABBVIE INC. $2,196.97 07/08/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202497220
Principal investigator 1 ABBVIE INC. $12,079.00 07/02/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis No dispute reported 06/30/2026 1202494321
Principal investigator 1 ABBVIE INC. $34,444.60 07/02/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202495149
Principal investigator 1 ABBVIE INC. $14,240.15 06/03/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202489225
Principal investigator 1 ABBVIE INC. $23,499.85 05/07/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202482759
Principal investigator 1 ABBVIE INC. $2,304.70 05/07/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202482761
Principal investigator 1 ABBVIE INC. $7,600.65 04/03/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202473900
Principal investigator 1 ABBVIE INC. $2,304.70 04/03/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202473903
Principal investigator 1 ABBVIE INC. $5,425.80 03/07/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
M20-465 - A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202460944
Principal investigator 1 ABBVIE INC. $2,122.59 02/06/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
M24-601 - A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202447433
Principal investigator 1 ABBVIE INC. $21,428.95 02/06/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
M20-465 - A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa No dispute reported 06/30/2026 1202447437
Principal investigator 1 ABBVIE INC. $2,122.59 01/02/2025 Non-covered Recipient Entity
OLIVER STREET 501 (A) INC
M24-601 - A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202434003